apo-ipravent sterules
apotex nz ltd - ipratropium bromide monohydrate 500 µg/ml - solution for inhalation - 500 mcg - active: ipratropium bromide monohydrate 500 µg/ml excipient: hydrochloric acid sodium chloride water for injection
atrovent autohaler
boehringer ingelheim (nz) ltd - ipratropium bromide monohydrate 0.0042 g equivalent to 0.0040 g anhydrous per container - aerosol inhaler, metered dose - 20 mcg/dose - active: ipratropium bromide monohydrate 0.0042 g equivalent to 0.0040 g anhydrous per container excipient: cryofluorane dichlorodifluoromethane lecithin trichlorofluoromethane
atrovent forte
boehringer ingelheim (nz) ltd - ipratropium bromide monohydrate 0.008 g (per container, 40µg/dose) - aerosol inhaler, metered dose - 40 mcg/dose - active: ipratropium bromide monohydrate 0.008 g (per container, 40µg/dose) excipient: cryofluorane dichlorodifluoromethane phosphatidylcholines, soya, hydrogenated trichlorofluoromethane
atrovent forte pulmatic
boehringer ingelheim (nz) ltd - ipratropium bromide monohydrate 0.008 g (per container) - aerosol inhaler, metered dose - 40 mcg/dose - active: ipratropium bromide monohydrate 0.008 g (per container) excipient: cryofluorane dichlorodifluoromethane lecithin trichlorofluoromethane
atrovent nasal aqueous
boehringer ingelheim (nz) ltd - ipratropium bromide monohydrate 0.3131 mg/ml equivalent to 0.03% w/v anhydrous - nasal spray solution - 0.03% w/v - active: ipratropium bromide monohydrate 0.3131 mg/ml equivalent to 0.03% w/v anhydrous excipient: benzalkonium chloride disodium edetate dihydrate purified water sodium chloride
atrovent nasal forte
boehringer ingelheim (nz) ltd - ipratropium bromide monohydrate 0.6262 mg/ml - nasal spray solution - 0.06% w/v - active: ipratropium bromide monohydrate 0.6262 mg/ml excipient: benzalkonium chloride disodium edetate dihydrate hydrochloric acid purified water sodium chloride sodium hydroxide
atrovent nasal spray
boehringer ingelheim (nz) ltd - ipratropium bromide monohydrate 0.0042 g (per container, equiv to 0.004g anhydrous, 20µg/dose) - nasal spray solution - 20 mcg/dose - active: ipratropium bromide monohydrate 0.0042 g (per container, equiv to 0.004g anhydrous, 20µg/dose) excipient: propellent mixture 11/12/114 to 14g phosphatidylcholines, soya, hydrogenated
atrovent paediatric respules
boehringer ingelheim (nz) ltd - ipratropium bromide monohydrate 0.1305 mg/ml equivalent to 0.125 mg/ml sch 1000 br anydrous - solution for inhalation - 0.25 mg/2ml - active: ipratropium bromide monohydrate 0.1305 mg/ml equivalent to 0.125 mg/ml sch 1000 br anydrous excipient: hydrochloric acid purified water sodium chloride
atrovent pulmatic
boehringer ingelheim (nz) ltd - ipratropium bromide monohydrate 20ug - aerosol inhaler, metered dose - 20 mcg/dose - active: ipratropium bromide monohydrate 20ug excipient: propellant= freons 11/12/114 lecithin trichlorofluoromethane
atrovent respules
boehringer ingelheim (nz) ltd - ipratropium bromide monohydrate 0.25 mg/ml - solution for inhalation - 0.5 mg/2ml - active: ipratropium bromide monohydrate 0.25 mg/ml excipient: hydrochloric acid purified water sodium chloride